-
Tips for becoming a good boxer - November 6, 2020
-
7 expert tips for making your hens night a memorable one - November 6, 2020
-
5 reasons to host your Christmas party on a cruise boat - November 6, 2020
-
What to do when you’re charged with a crime - November 6, 2020
-
Should you get one or multiple dogs? Here’s all you need to know - November 3, 2020
-
A Guide: How to Build Your Very Own Magic Mirror - February 14, 2019
-
Our Top Inspirational Baseball Stars - November 24, 2018
-
Five Tech Tools That Will Help You Turn Your Blog into a Business - November 24, 2018
-
How to Indulge on Vacation without Expanding Your Waist - November 9, 2018
-
5 Strategies for Businesses to Appeal to Today’s Increasingly Mobile-Crazed Customers - November 9, 2018
South San Francisco’s KaloBios Fires Pharma CEO Martin Shkreli
KaloBios has announced that Martin Shkreli resigned from its board of directors and was removed from his approximately month-long tenure as the biotech’s CEO following his arrest last Thursday.
Advertisement
He’s been dubbed the internet’s most hated man and is now facing fraud charges, so we reckon it was just a matter of time before this happened.
Shkreli, 32, who is free on $5 million bail, maintains that he is innocent and will be vindicated.
THE under-fire hedge fund manager and entrepreneur Martin Shkreli has been fired from his role as CEO of a Californian pharmaceuticals company.
His arrest on securities fraud charges stem from Shkreli’s hedge fund, MSMB Capital Management, and Retrophin, another pharmaceutical company. The University of California-Davis also suspended a planned drug trial with the company after the arrest, Bloomberg reported. Its shares tumbled 70 percent in January after its drug for lung infections failed in testing. The company also said that the toxoplasmosis drug Daraprimp will continue to be available to providers and patients despite Shkreli’s indictment and ouster. (AP Photo/Craig Ruttle)Shkreli’s charged with losing investors’ money through bad trades – then taking $11 million from his former company to pay disgruntled clients.
“It was hacked”, Craig Stevens, a spokesman for the former CEO of Turing Pharmaceuticals, confirmed to Reuters.
A day later, his Twitter account, which now features the name “Martin the God”, got hacked.
Shkreli has refused to apologize for jacking up the price of Daraprim from $13.50 to $750 a dose, and told a drug conference that he would like to have raised the prices higher to please his investors. The company wouldn’t answer questions Monday about who will take control and when its shares will resume trading. The drug under testing known as KB003, is meant for use in the treatment of leukemia.
KaloBios also announced today that Tony Chase, who joined the board along with Shkreli back in November, has also resigned.
Advertisement
Shkreli, through his press relations firm, said he is confident he will be cleared of all charges, adding that some of the charges involved “complex accounting matters” that authorities failed to understand.